Search Cart My Vazyme
TOP
About Us Our Company
Vazyme (688105.SH) is a global technology and service provider that specializes in the design, manufacture, and application of bioactive compounds and continuously expands the application fields of core technologies in life sciences, in vitro diagnostics, bio-medicine, and exploratory business. To meet the varying needs of our customers and partners, we have developed over 200 types of genetically engineered recombinant enzymes and over 1,000 types of high-performance materials and over 1,000 end products. While remaining steadfast to high quality standards, producing all core materials in-house and adhering to GMP quality control standards, we endeavor to maintain a stable and sufficient supply for global customers by establishing wholly-owned branches and localized service teams. Currently, Vazyme has served customers in over 60 countries and regions with wholly-owned branches offices in the U.S., Germany, Indonesia, Singapore and Hong Kong SAR.
34,000 ㎡+
Production Area
$150 Million+
R&D Investment
60,000+
Citations in Scientific Journals
200+
Genetically Engineered Recombinant Enzymes
3,000+
Number of Employees
60+
Countries Served

We Focus on Tech Innovation

Four self-developed key technology platforms the foundation for our products, solutions, and services

Protein Directed Modification & Evolution Platform
For high-end products: Improved products performance via leading-edge technology platform
High Performance Antibody Discovery Platform (Based on Single B Cell)
For difficult and scarce products: Enhance antibody screening efficiency and shorten development cycle
Multi-system Recombinant Protein Preparation Platform
For safer supply chain: Increase the unit production capacity to world leading level
Quantum Dot Modified Coupling and Multi-index Joint Inspection Technology Platform
For higher efficiency with lower cost: Multiple test results for one sample in one step
1,000+Scientific Research Institutions
700+High-throughput Sequencing Service Companies
700+Molecular Diagnostic Reagent Manufacturers
200+Pharmaceutical Companies and CRO Companies
2,200+Hospitals, Third-party Testing and Medical Examination Institutions,etc.